NDC Package 51754-5060-1 Betamethasone Sodium Phosphate And Betamethasone Acetate

Injection, Suspension Intra-articular; Intralesional; Intramuscular; Soft Tissue - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51754-5060-1
Package Description:
1 VIAL, MULTI-DOSE in 1 BOX / 5 mL in 1 VIAL, MULTI-DOSE
Product Code:
Proprietary Name:
Betamethasone Sodium Phosphate And Betamethasone Acetate
Non-Proprietary Name:
Betamethasone Sodium Phosphate And Betamethasone Acetate
Substance Name:
Betamethasone Acetate; Betamethasone Sodium Phosphate
Usage Information:
When oral therapy is not feasible, the intramuscular use of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated as follows:
11-Digit NDC Billing Format:
51754506001
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 578803 - betamethasone sodium phosphate / betamethasone acetate 6 MG/ML Injectable Suspension
  • RxCUI: 578803 - betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension
  • RxCUI: 578803 - betamethasone 3 MG/ML (as betamethasone sodium phosphate) / betamethasone acetate 3 MG/ML Injectable Suspension
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Exela Pharma Sciences, Llc
    Dosage Form:
    Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
    Administration Route(s):
  • Intra-articular - Administration within a joint.
  • Intralesional - Administration within or introduced directly into a localized lesion.
  • Intramuscular - Administration within a muscle.
  • Soft Tissue - Administration into any soft tissue.
  • Sample Package:
    No
    FDA Application Number:
    NDA014602
    Marketing Category:
    NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
    Start Marketing Date:
    06-01-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 51754-5060-1 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    51754506001J0702Betamethasone acet&sod phosp3 MG & 3 MG5155

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51754-5060-1?

    The NDC Packaged Code 51754-5060-1 is assigned to a package of 1 vial, multi-dose in 1 box / 5 ml in 1 vial, multi-dose of Betamethasone Sodium Phosphate And Betamethasone Acetate, a human prescription drug labeled by Exela Pharma Sciences, Llc. The product's dosage form is injection, suspension and is administered via intra-articular; intralesional; intramuscular; soft tissue form.

    Is NDC 51754-5060 included in the NDC Directory?

    Yes, Betamethasone Sodium Phosphate And Betamethasone Acetate with product code 51754-5060 is active and included in the NDC Directory. The product was first marketed by Exela Pharma Sciences, Llc on June 01, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 51754-5060-1?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 51754-5060-1?

    The 11-digit format is 51754506001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151754-5060-15-4-251754-5060-01